# Epicrispr Biotechnologies

**Source:** https://www.startuphub.ai/startups/epicrispr-biotechnologies
**Profile type:** Startup

> Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

## About

Epicrispr Biotechnologies is a clinical-stage biotechnology company pioneering gene-modulating therapies. They are focused on developing a new class of programmable epigenetic medicines designed to durably regulate gene expression without permanently altering the underlying DNA sequence. Their lead program, EPI-321, is in clinical trials for Facioscapulohumeral Muscular Dystrophy (FSHD).

## Key facts

- **Slug:** epicrispr-biotechnologies
- **Website:** https://www.epicrispr.com/
- **Location:** South San Francisco, United States
- **Founded:** 2020-01-01
- **Employees:** 51
- **Operating status:** Active
- **Total funding:** $90M
- **Sectors / tags:** Biotechnology, Therapeutics, Rare Diseases, Epigenetics, Biotech, MedTech, Genomics, Drug Discovery, Clinical Trials, Epigenetic Reprogramming, Gene Therapy, Neuromuscular Diseases
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/epicrispr-biotechnologies/

## Frequently asked

### What does Epicrispr Biotechnologies do?

Epicrispr Biotechnologies is a clinical-stage biotechnology company pioneering gene-modulating therapies. They are focused on developing a new class of programmable epigenetic medicines designed to durably regulate gene expression without permanently altering the underlying DNA sequence. Their lead program, EPI-321, is in clinical trials for Facioscapulohumeral Muscular Dystrophy (FSHD).

### Is Epicrispr Biotechnologies trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Epicrispr Biotechnologies is 52 out of 100, based on site security posture and privacy practices.

### What is Epicrispr Biotechnologies's revenue?

StartupHub estimates Epicrispr Biotechnologies's annual revenue at $5.9M (range $3.1M to $18.0M, 69% confidence), based on comparable companies in the sector.

### What is Epicrispr Biotechnologies's valuation?

StartupHub estimates Epicrispr Biotechnologies's effective valuation at $381.6M (range $225.0M to $540.0M, 25% confidence), based on comparable companies in the sector.

### How much funding has Epicrispr Biotechnologies raised?

Epicrispr Biotechnologies has raised a total of $90M in funding. The most recent round on record is Series C.

### Where is Epicrispr Biotechnologies headquartered?

Epicrispr Biotechnologies is headquartered in South San Francisco, United States.

### When was Epicrispr Biotechnologies founded?

Epicrispr Biotechnologies was founded in 2020.

### What industry does Epicrispr Biotechnologies operate in?

Epicrispr Biotechnologies operates in Biotechnology, Therapeutics, Rare Diseases, Epigenetics, Biotech, MedTech.

### How many employees does Epicrispr Biotechnologies have?

Epicrispr Biotechnologies has approximately 51 people on record.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Epicrispr Biotechnologies",
          "item": "https://www.startuphub.ai/startups/epicrispr-biotechnologies"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/epicrispr-biotechnologies#webpage",
      "url": "https://www.startuphub.ai/startups/epicrispr-biotechnologies",
      "name": "Epicrispr Biotechnologies - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Epicrispr Biotechnologies. Epicrispr Biotechnologies is a startup founded in 2020, operating in Biotechnology and Therapeutics. Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). Headquartered in South San Francisco, United States. The company has approximately 51 employees.",
      "dateModified": "2026-08-18T06:01:14.653+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/epicrispr-biotechnologies#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/epicrispr-biotechnologies#organization",
      "name": "Epicrispr Biotechnologies",
      "url": "https://www.epicrispr.com/",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/4a19c47d-3602-43cc-9198-3f68de11e5ca-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/4a19c47d-3602-43cc-9198-3f68de11e5ca-square.webp",
      "description": "This is the official profile of Epicrispr Biotechnologies. Epicrispr Biotechnologies is a startup founded in 2020, operating in Biotechnology and Therapeutics. Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). Headquartered in South San Francisco, United States. The company has approximately 51 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/epicrispr-biotechnologies/",
        "https://www.startuphub.ai/startups/epicrispr-biotechnologies"
      ],
      "foundingDate": "2020-01-01",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 51
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "South San Francisco",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Biotechnology",
        "Therapeutics",
        "Rare Diseases",
        "Epigenetics",
        "Biotech",
        "MedTech",
        "Genomics",
        "Drug Discovery",
        "Clinical Trials",
        "Epigenetic Reprogramming",
        "Gene Therapy",
        "Neuromuscular Diseases"
      ]
    }
  ]
}
```